Antibiotics Market Size (2024 - 2029)

Antibiotics Market Analysis

The Antibiotics Market size is estimated at USD 53.43 billion in 2024, and is expected to reach USD 65.22 billion by 2029, growing at a CAGR of 4.07% during the forecast period (2024-2029).

The outbreak of COVID-19 significantly impacted the Antibiotics Market. During the initial phase of the pandemic, the demand for antibiotics, including Antibacterial Drugs, increased for treating COVID-19. For instance, in March 2020, Pfizer announced positive data using azithromycin (Zithromax) and hydroxychloroquine in a coronavirus (COVID-19) clinical trial performed in France. Following these trials, azithromycin became a widely used drug for treating COVID-19. Furthermore, according to a July 2021 NCBI research article and as per the Mordor Intelligence analysis, COVID-19 contributed to about 216.0 million excess doses of non-CAF (child-appropriate formulations) of antibiotics in total and 38 million extra doses of azithromycin between June and September 2020 in India, impacting the Antibiotics Market Size in India. Therefore, the market witnessed high growth during the pandemic due to such high demand for antibiotics. However, it is expected to observe stable growth after the pandemic.

The emergence of Anti-MRSA/VRE drugs, the increasing burden of infectious diseases, the vulnerable aging population, and the need for effective and newer antibiotics are driving the Antibiotics Market growth. For instance, according to the October 2022 report of the WHO, around 10.6 million people suffered from TB in 2021. It was an increase of 4.5% from 2020, and 1.6 million people died from TB across the globe. The same source also reported that the burden of drug-resistant TB (DR-TB) increased by 3.0% between 2020 and 2021, with 450,000 new cases of rifampicin-resistant TB (RR-TB) in 2021. Furthermore, one-third of the cases were reported from eight countries, including India, China, Indonesia, Philippines, Pakistan, Nigeria, Bangladesh, and South Africa. Therefore, such a high prevalence of infectious diseases may propel the demand for antibiotics, further surging the Antibacterial Drugs Market growth.

Urbanization, destruction of natural habitats, climate change, and changing ecosystems are major factors contributing to the high rate of infectious diseases across all age groups. For instance, as per the UNICEF data published in August 2022, there were more than 1,400 cases of pneumonia per 100,000 children globally, with the highest incidence occurring in South Asia (2,500 cases per 100,000 children) and West and Central Africa (1,620 cases per 100,000 children). Similarly, as per the ERS journal of 2021, it was estimated that around 36,580,965 Europeans suffered from COPD in 2020. According to Mordor Intelligence analysis, approximately 49,453,852 Europeans will suffer from COPD in 2050. Antibiotics, including Broad Spectrum Antibiotics, are widely used for treating various types of diseases. Therefore, such a high disease prevalence is anticipated to positively impact the Antibiotics Market growth over the forecast period.

However, factors such as antibiotic resistance and fewer companies involved in active research are expected to impede the growth of the Antibiotic Industry over the forecast period.

Antibiotics Industry Segmentation

As per the scope of the report, antibiotic medicines refer to medicines used to treat infections by killing bacteria. These are among the most prescribed courses worldwide in fighting bacterial infections, primarily in outpatient settings. The Antibiotics Market is segmented by product (Cephalosporins, Penicillin, Fluoroquinolones, Macrolides, Carbapenems, Aminoglycosides, Sulfonamides, and other product types), spectrum (broad-spectrum antibiotics, narrow-spectrum antibiotics, and other spectrums), and geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers values (in USD million) for the above segments.